AVAI BIO, INC. (AVAI)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD.

Revenue TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Gross Profit TTM

-1.1M -700K -350K 0 350K 700K 1.1M Q4 '20: -256.3K Q1 '21: -177.7K Q4 '22: -210.8K Q1 '23: -729.2K Q2 '23: -629.2K Q3 '23: -992.7K Q4 '23: -40.5K Q4 '20 Q1 '21 Q4 '22 Q1 '23 Q2 '23 Q3 '23 Q4 '23

Operating Income TTM

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q2 '22: 171.4K Q3 '22: 103.6K Q4 '22: 126.5K Q1 '23: 552.6K Q2 '23: 470.1K Q3 '23: 231.2K Q4 '23: -348.9K Q1 '24: 32.8K Q2 '24: 348.7K Q3 '24: 1.3M Q4 '24: -2.1M Q1 '25: -3.1M Q2 '25: -2.8M Q3 '25: -3.4M Q4 '25: -1.1M Q1 '26: -125.7K Q2 '26: -1.2M Q3 '26: -2.2M Q4 '26: -774.3K Q1 '27: -1.8M Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27

Net Income TTM

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q4 '19: -78.2K Q1 '20: -113.9K Q4 '22: -126.5K Q1 '23: -552.6K Q2 '23: -470.1K Q3 '23: -231.2K Q4 '23: -796.9K Q1 '24: -1.2M Q2 '24: -1.5M Q3 '24: -2.4M Q4 '24: -5.8M Q1 '25: -5.9M Q2 '25: -6.1M Q3 '25: -5.6M Q4 '25: -1.1M Q1 '26: -125.7K Q2 '26: 46.3K Q3 '26: -55.1K Q4 '26: -774.3K Q1 '27: -1.8M Q1 '20 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27

Cost of Revenue TTM

0 500K 1M 1.5M Q4 '20: 461.1K Q1 '21: 675.7K Q4 '21: 1.2M Q1 '22: 1.2M Q2 '22: 1.1M Q3 '22: 946.4K Q4 '22: 710.5K Q1 '23: 598.3K Q2 '23: 446.1K Q3 '23: 328.7K Q4 '23: 316.8K Q4 '25: 14.8K Q1 '21 Q1 '22 Q3 '22 Q1 '23 Q3 '23 Q4 '25

Operating Cash Flow TTM

-1.8M -1.2M -600K 0 600K 1.2M 1.8M Q4 '19: -84.2K Q1 '20: -84.5K Q4 '21: -16.2K Q1 '22: 64.8K Q2 '22: 346.9K Q3 '22: 939K Q4 '23: -54.5K Q1 '24: -18.6K Q2 '24: -521K Q3 '24: -1.3M Q4 '24: -1.3M Q1 '25: -1.3M Q2 '25: -1.7M Q3 '25: -1.1M Q4 '25: -1.2M Q1 '26: -1.4M Q2 '26: -933.7K Q3 '26: -1.1M Q4 '26: -1M Q1 '27: -1.2M Q1 '20 Q2 '22 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27

Free Cash Flow TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Quarterly

0 60M 120M 180M Q3 '20: 5M Q1 '21: 26.3M Q2 '21: 26.3M Q3 '21: 26.3M Q1 '22: 26.3M Q2 '22: 26.3M Q3 '22: 26.3M Q1 '23: 26.3M Q2 '23: 32.2M Q3 '23: 32.2M Q1 '24: 57.6M Q2 '24: 74.3M Q3 '24: 74.8M Q1 '25: 115.8M Q2 '25: 123.6M Q3 '25: 137M Q1 '26: 137.5M Q2 '26: 137.6M Q3 '26: 138M Q1 '27: 153.9M Q1 '21 Q1 '22 Q1 '23 Q1 '24 Q1 '25 Q1 '26 Q1 '27

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.02 -0.01 -0.01 0.00 0.01 0.01 0.02 Q2 '22: 0.00 Q3 '22: 0.00 Q4 '22: 0.00 Q1 '23: 0.00 Q2 '23: 0.00 Q3 '23: 0.00 Q4 '23: 0.00 Q1 '24: 0.00 Q2 '24: -0.01 Q3 '24: -0.02 Q4 '24: -0.02 Q1 '25: -0.02 Q2 '25: -0.02 Q3 '25: -0.01 Q4 '25: -0.01 Q1 '26: -0.01 Q2 '26: 0.00 Q3 '26: 0.00 Q4 '26: 0.00 Q1 '27: 0.00 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26 Q1 '27

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.